TULSA Effective in Controlling Prostate Cancer Long-Term
WASHINGTON — Results from a long-term follow-up of the pivotal TACT trial showed that MRI-guided transurethral ultrasound ablation (TULSA) was effective and durable in men with localized prostate cancer. The median prostate-specific antigen (PSA) level at 5 years was 0.63 ng/mL — a 90% reduction from the median PSA at baseline, reported Scott Eggener, MD, […]